|
|
|
Insider
Information: |
Martin John C |
Relationship: |
Director |
City: |
Foster City |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
2,895,138 |
|
Indirect Shares
|
2,684,281 |
|
|
Direct
Value |
$189,361,486 |
|
|
Indirect Value
|
$47,757,584 |
|
|
Total
Shares |
5,579,419 |
|
|
Total
Value |
$237,119,070 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Gilead Sciences Inc |
GILD |
Director |
2019-02-06 |
2,887,225 |
2016-08-05 |
731,917 |
Premium* |
|
Sarepta Therapeutics Inc |
SRPT |
Director |
2021-03-03 |
7,913 |
2020-02-28 |
0 |
Premium* |
|
Kronos Bio, Inc. |
KRON |
Director |
2020-10-14 |
0 |
2020-10-14 |
1,952,364 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
367 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 8 of 15
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2009-01-13 |
4 |
OE |
$3.65 |
$364,850 |
D/D |
100,000 |
1,677,253 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2009-02-10 |
4 |
OE |
$3.65 |
$364,850 |
D/D |
100,000 |
1,677,253 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2009-02-10 |
4 |
S |
$50.71 |
$5,087,073 |
D/D |
(100,000) |
1,577,253 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2009-03-10 |
4 |
OE |
$3.65 |
$364,850 |
D/D |
100,000 |
1,677,253 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2009-03-10 |
4 |
S |
$44.07 |
$4,407,390 |
D/D |
(100,000) |
1,577,253 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2009-04-14 |
4 |
S |
$46.28 |
$4,628,070 |
D/D |
(100,000) |
1,596,239 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2009-04-14 |
4 |
OE |
$3.65 |
$364,850 |
D/D |
100,000 |
1,696,239 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2009-05-12 |
4 |
S |
$44.63 |
$4,463,320 |
D/D |
(100,000) |
1,596,239 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2009-05-12 |
4 |
OE |
$3.65 |
$364,850 |
D/D |
100,000 |
1,696,239 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2009-06-09 |
4 |
OE |
$3.65 |
$364,850 |
D/D |
100,000 |
1,696,239 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2009-06-09 |
4 |
S |
$44.36 |
$4,436,470 |
D/D |
(100,000) |
1,596,239 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2009-07-14 |
4 |
OE |
$3.65 |
$364,850 |
D/D |
100,000 |
1,696,718 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2009-07-14 |
4 |
S |
$45.01 |
$4,501,290 |
D/D |
(100,000) |
1,596,718 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2009-08-11 |
4 |
OE |
$3.70 |
$370,320 |
D/D |
100,000 |
1,696,718 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2009-08-11 |
4 |
S |
$45.44 |
$4,543,710 |
D/D |
(100,000) |
1,596,718 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2009-09-08 |
4 |
OE |
$3.70 |
$370,320 |
D/D |
100,000 |
1,696,718 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2009-09-08 |
4 |
S |
$46.68 |
$4,667,870 |
D/D |
(100,000) |
1,596,718 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2009-10-13 |
4 |
S |
$45.40 |
$4,540,070 |
D/D |
(100,000) |
1,596,718 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2009-10-13 |
4 |
OE |
$3.70 |
$370,320 |
D/D |
100,000 |
1,696,718 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2009-11-10 |
4 |
OE |
$3.70 |
$370,320 |
D/D |
100,000 |
1,696,718 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2009-11-10 |
4 |
S |
$46.65 |
$4,666,614 |
D/D |
(100,000) |
1,596,718 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2009-12-08 |
4 |
S |
$46.16 |
$4,616,300 |
D/D |
(100,000) |
1,596,718 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2009-12-08 |
4 |
OE |
$3.70 |
$370,320 |
D/D |
100,000 |
1,696,718 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2010-01-12 |
4 |
S |
$44.80 |
$4,479,970 |
D/D |
(100,000) |
1,596,718 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2010-01-12 |
4 |
OE |
$3.70 |
$370,059 |
D/D |
100,000 |
1,696,718 |
0 |
- |
|
367 Records found
|
|
Page 8 of 15 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|